Mark Eisner
Director/Board Member presso The Genentech Foundation
Patrimonio netto: 375 805 $ in data 31/03/2024
Profilo
Il Dr. Mark Eisner, MD, è il responsabile medico di FibroGen, Inc. Il Dr. Eisner è stato precedentemente impiegato come vicepresidente senior presso Genentech, Inc. e professore presso l'Università della California, San Francisco. Ha conseguito la laurea presso la Stanford University, il dottorato presso la UC Berkeley School of Public Health e il dottorato presso la University of Pennsylvania Medical Center.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
FIBROGEN, INC.
0.16% | 06/09/2023 | 159 917 ( 0.16% ) | 375 805 $ | 31/03/2024 |
Posizioni attive di Mark Eisner
Società | Posizione | Inizio |
---|---|---|
The Genentech Foundation | Director/Board Member | - |
Precedenti posizioni note di Mark Eisner
Società | Posizione | Fine |
---|---|---|
FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 08/09/2023 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
Formazione di Mark Eisner
Stanford University | Undergraduate Degree |
UC Berkeley School of Public Health | Doctorate Degree |
University of Pennsylvania Medical Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
FIBROGEN, INC. | Health Technology |
Aziende private | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Genentech Foundation | Miscellaneous |
- Borsa valori
- Insiders
- Mark Eisner